GlycosBio’s business plan and go to market strategy consists of a focused effort on micro biology and metabolic engineering research and commercialization around feedstock sources and end product biochemicals that are compatible and align with a wide variety of industry partners.
Our business objectives support a number of industries as our intellectual property and technology portfolio support a number of diverse non food based feedstocks and a wide range of metabolic pathways or routes to a diverse set of chemicals.
This diversity in feedstocks and end product green chemicals positions GlycosBio uniquely across a wide range of partner industries.